Status:
NOT_YET_RECRUITING
Effects of tDCS on Cognitive Flexibility and EEG Oscillations in Orthorexia Nervosa
Lead Sponsor:
Istanbul Medipol University Hospital
Conditions:
Orthorexia Nervosa
Eligibility:
All Genders
18-40 years
Phase:
NA
Brief Summary
Orthorexia Nervosa (ON); is a condition characterized by individuals being overly focused on healthy eating habits, constantly checking and classifying the foods they will consume. ON has not yet been...
Detailed Description
Measurement instruments: Informed Voluntary Consent Form Demographic Information Form Edinburgh Hand Preference Survey Beck Depression Scale Test of Orthorexia Nervosa (TON-17) Cognitive Flexibility ...
Eligibility Criteria
Inclusion
- Being between the ages of 18-40,
- Having a score of 17 or less on the Beck Depression Inventory
- Having a score of 61 or more on the Test for Orthorexia Nervosa (TON-17) for the orthorexia group
Exclusion
- Having a history of serious neurological and psychiatric illness,
- Currently taking medication that alters the cortical excitability level,
- Having visual defects that cannot be corrected with glasses
- Use of intracranial metal objects, implanted stimulating devices or pacemakers
Key Trial Info
Start Date :
September 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2026
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT07141979
Start Date
September 1 2025
End Date
July 1 2026
Last Update
August 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Istanbul Medipol University
Istanbul, Turkey (Türkiye)